Literature DB >> 26202119

Ultradeep Sequencing for Detection of Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients.

Laura Navika Yamani1, Yoshihiko Yano2, Takako Utsumi1, Hadi Wandono3, Doddy Widjanarko4, Ari Triantanoe4, Widya Wasityastuti5, Yujiao Liang6, Rina Okada7, Toshihito Tanahashi8, Yoshiki Murakami9, Takeshi Azuma7, Maria Inge Lusida10, Yoshitake Hayashi6.   

Abstract

Quasispecies of hepatitis B virus (HBV) with variations in the major hydrophilic region (MHR) of the HBV surface antigen (HBsAg) can evolve during infection, allowing HBV to evade neutralizing antibodies. These escape variants may contribute to chronic infections. In this study, we looked for MHR variants in HBV quasispecies using ultradeep sequencing and evaluated the relationship between these variants and clinical manifestations in infected patients. We enrolled 30 Indonesian patients with hepatitis B infection (11 with chronic hepatitis and 19 with advanced liver disease). The most common subgenotype/subtype of HBV was B3/adw (97%). The HBsAg titer was lower in patients with advanced liver disease than that in patients with chronic hepatitis. The MHR variants were grouped based on the percentage of the viral population affected: major, ≥20% of the total population; intermediate, 5% to <20%; and minor, 1% to <5%. The rates of MHR variation that were present in the major and intermediate viral population were significantly greater in patients with advanced liver disease than those in chronic patients. The most frequent MHR variants related to immune evasion in the major and intermediate populations were P120Q/T, T123A, P127T, Q129H/R, M133L/T, and G145R. The major population of MHR variants causing impaired of HBsAg secretion (e.g., G119R, Q129R, T140I, and G145R) was detected only in advanced liver disease patients. This is the first study to use ultradeep sequencing for the detection of MHR variants of HBV quasispecies in Indonesian patients. We found that a greater number of MHR variations was related to disease severity and reduced likelihood of HBsAg titer.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26202119      PMCID: PMC4572547          DOI: 10.1128/JCM.00602-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  71 in total

1.  Molecular epidemiology of hepatitis B virus mutants.

Authors:  A J Zuckerman; J N Zuckerman
Journal:  J Med Virol       Date:  1999-07       Impact factor: 2.327

2.  Chronic hepatitis B.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

Review 3.  New virologic tools for management of chronic hepatitis B and C.

Authors:  Stéphane Chevaliez; Christophe Rodriguez; Jean-Michel Pawlotsky
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

4.  Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir.

Authors:  Munira Hussain; Scott Fung; Evelien Libbrecht; Erwin Sablon; Carmela Cursaro; Pietro Andreone; Anna S F Lok
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

5.  Distribution of the hepatitis B surface antigen subtypes in Indonesia: implications for ethnic heterogeneity and infection control measures.

Authors:  F Tsuda; A T Karossi; S Soewignjo; D Sumarsidi; R H Trisnamurti; L Z Udin; K Kanai; S Mishiro
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

6.  Unusual hepatitis B surface antigen variation in a child immunised against hepatitis B.

Authors:  L Roznovsky; T J Harrison; Z L Fang; R Ling; I Lochman; I Orsagova; L Pliskova
Journal:  J Med Virol       Date:  2000-05       Impact factor: 2.327

7.  Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus.

Authors:  Y Ogura; M Kurosaki; Y Asahina; N Enomoto; F Marumo; C Sato
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

8.  Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease.

Authors:  Chun-Jen Liu; Jia-Horng Kao; Wen-Yi Shau; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen
Journal:  J Med Virol       Date:  2002-09       Impact factor: 2.327

9.  Hepatitis B virus pre-S2 start codon mutations in Indonesian liver disease patients.

Authors:  Andi Utama; Marlinang Diarta Siburian; Ismail Fanany; Mariana Destila Bayu Intan; Rama Dhenni; Tri Shinta Kurniasih; Syafruddin A R Lelosutan; Wenny Astuti Achwan; Nasrul Zubir; Benyamin Lukito; Irawan Yusuf; Laurentius Adrianus Lesmana; Ali Sulaiman
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

10.  Viral population estimation using pyrosequencing.

Authors:  Nicholas Eriksson; Lior Pachter; Yumi Mitsuya; Soo-Yon Rhee; Chunlin Wang; Baback Gharizadeh; Mostafa Ronaghi; Robert W Shafer; Niko Beerenwinkel
Journal:  PLoS Comput Biol       Date:  2008-05-09       Impact factor: 4.475

View more
  8 in total

Review 1.  Current hepatitis B virus infection situation in Indonesia and its genetic diversity.

Authors:  Maria Inge Lusida; Yoshihiko Yano
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

2.  Analysis of Quasispecies of Avain Leukosis Virus Subgroup J Using Sanger and High-throughput Sequencing.

Authors:  Fanfeng Meng; Xuan Dong; Tao Hu; Yingnan Liu; Yingjie Zhao; Yanyan Lv; Shuang Chang; Peng Zhao; Zhizhong Cui
Journal:  Virol J       Date:  2016-06-27       Impact factor: 4.099

3.  Quasispecies variant of pre-S/S gene in HBV-related hepatocellular carcinoma with HBs antigen positive and occult infection.

Authors:  Yuri Hatazawa; Yoshihiko Yano; Rina Okada; Toshihito Tanahashi; Hiroki Hayashi; Hirotaka Hirano; Akihiro Minami; Yuki Kawano; Motofumi Tanaka; Takumi Fukumoto; Yoshiki Murakami; Masaru Yoshida; Yoshitake Hayashi
Journal:  Infect Agent Cancer       Date:  2018-02-02       Impact factor: 2.965

4.  Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population.

Authors:  Mikael Gencay; Kirsten Hübner; Peter Gohl; Anja Seffner; Michael Weizenegger; Dionysios Neofytos; Richard Batrla; Andreas Woeste; Hyon-Suk Kim; Gaston Westergaard; Christine Reinsch; Eva Brill; Pham Thi Thu Thuy; Bui Huu Hoang; Mark Sonderup; C Wendy Spearman; Stephan Pabinger; Jérémie Gautier; Giuseppina Brancaccio; Massimo Fasano; Teresa Santantonio; Giovanni B Gaeta; Markus Nauck; Wolfgang E Kaminski
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

5.  Clinical features and viral quasispecies characteristics associated with infection by the hepatitis B virus G145R immune escape mutant.

Authors:  Yuan Xue; Ming-Jie Wang; Zhi-Tao Yang; De-Min Yu; Yue Han; Dao Huang; Dong-Hua Zhang; Xin-Xin Zhang
Journal:  Emerg Microbes Infect       Date:  2017-03-22       Impact factor: 7.163

6.  Genetic variation of hepatitis B surface antigen among acute and chronic hepatitis B virus infections in The Netherlands.

Authors:  Jeroen Cremer; Sanne H I Hofstraat; Francoise van Heiningen; Irene K Veldhuijzen; Birgit H B van Benthem; Kimberley S M Benschop
Journal:  J Med Virol       Date:  2018-06-07       Impact factor: 2.327

7.  Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia.

Authors:  Carlos Mario Jaramillo; Fernando de La Hoz; Alexandra Porras; Diana di Filippo; Luz Angela Choconta-Piraquive; Edra Payares; Neyla Montes; Maria-Cristina Navas
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

8.  Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic history.

Authors:  Yuan O Zhu; Pauline P K Aw; Paola Florez de Sessions; Shuzhen Hong; Lee Xian See; Lewis Z Hong; Andreas Wilm; Chen Hao Li; Stephane Hue; Seng Gee Lim; Niranjan Nagarajan; William F Burkholder; Martin Hibberd
Journal:  BMC Genomics       Date:  2017-10-27       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.